Intellia therapeutics stock news

Get today's Intellia Therapeutics Inc stock news. We cover the latest Intellia Therapeutics Inc headlines and breaking news impacting Intellia Therapeutics Inc  Real-time trade and investing ideas on Intellia Therapeutics NTLA from the largest community of traders and investors.

Intellia Therapeutics, Inc. Common Stock (NTLA) News ... Find the latest news headlines from Intellia Therapeutics, Inc. Common Stock (NTLA) at Nasdaq.com. NTLA Stock Price | Intellia Therapeutics Inc. Stock Quote ... NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. NTLA Stock Price, Forecast & News (Intellia Therapeutics) 8 brokerages have issued 12-month price objectives for Intellia Therapeutics' stock. Their forecasts range from $16.00 to $57.50. On average, they expect Intellia Therapeutics' stock price to reach $26.42 in the next twelve months. This suggests a possible upside of 121.4% from the stock's current price. Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote ...

Intellia Therapeutics, Inc. (NTLA) stock price, quote ...

NTLA Stock Price Quote & News - Intellia Therapeutics ... View the real-time NTLA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Intellia Therapeutics against related stocks people have also bought like EDIT, CRSP, SGMO, and ILMN. 5,191 people own Intellia Therapeutics on Robinhood on April 4, 2020. Intellia Therapeutics Inc. - NASDAQ:NTLA - Stock Quote ... Apr 03, 2020 · View detailed financial information, real-time news, videos, quotes and analysis on Intellia Therapeutics Inc. (NASDAQ:NTLA). Explore commentary on Intellia Therapeutics Inc. and hear what the Intellia Therapeutics Inc. Stock Price (NTLA) | Barron's Apr 03, 2020 · View today's stock price, news and analysis for Intellia Therapeutics Inc. (NTLA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Get today's Intellia Therapeutics Inc stock news. We cover the latest Intellia Therapeutics Inc headlines and breaking news impacting Intellia Therapeutics Inc  Real-time trade and investing ideas on Intellia Therapeutics NTLA from the largest community of traders and investors. Exploring Intellia Therapeutics (NASDAQ:NTLA) stock? View NTLA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings  Prev Close 12.71, 52 Wk Low 9.18. Open 13.03, 52 Wk High 19.00. Day Low 12.00, Volume 446,939.00. Day High 13.09, Avg 10D Vol 555,064.00  Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 23.00, with a high estimate of 57.50  4 Mar 2020 The institutional investor bought 3.0 million shares of the stock in a transaction took place on 1/31/2020. In another most recent transaction, which  View today's stock price, news and analysis for Intellia Therapeutics Inc. (NTLA). Barron's also provides information on historical stock ratings, target prices, 

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system.

NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real -time stock prices and stock quotes for a full financial overview. Get today's Intellia Therapeutics Inc stock news. We cover the latest Intellia Therapeutics Inc headlines and breaking news impacting Intellia Therapeutics Inc  Real-time trade and investing ideas on Intellia Therapeutics NTLA from the largest community of traders and investors. Exploring Intellia Therapeutics (NASDAQ:NTLA) stock? View NTLA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings 

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system.

NTLA | Intellia Therapeutics Inc. Stock Price & News - WSJ View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Get the latest Intellia Therapeutics, Inc. (NTLA) stock news and headlines to help you in your trading and investing decisions. Intellia Therapeutics, Inc. Common Stock (NTLA) News ... Find the latest news headlines from Intellia Therapeutics, Inc. Common Stock (NTLA) at Nasdaq.com. NTLA Stock Price | Intellia Therapeutics Inc. Stock Quote ... NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.